FR2073364A1 - - Google Patents

Info

Publication number
FR2073364A1
FR2073364A1 FR7040956A FR7040956A FR2073364A1 FR 2073364 A1 FR2073364 A1 FR 2073364A1 FR 7040956 A FR7040956 A FR 7040956A FR 7040956 A FR7040956 A FR 7040956A FR 2073364 A1 FR2073364 A1 FR 2073364A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7040956A
Other languages
French (fr)
Other versions
FR2073364B1 (hu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2073364A1 publication Critical patent/FR2073364A1/fr
Application granted granted Critical
Publication of FR2073364B1 publication Critical patent/FR2073364B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FR7040956A 1969-11-17 1970-11-16 Expired FR2073364B1 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87744369A 1969-11-17 1969-11-17

Publications (2)

Publication Number Publication Date
FR2073364A1 true FR2073364A1 (hu) 1971-10-01
FR2073364B1 FR2073364B1 (hu) 1974-03-22

Family

ID=25369972

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7040956A Expired FR2073364B1 (hu) 1969-11-17 1970-11-16

Country Status (26)

Country Link
US (1) US3666856A (hu)
JP (1) JPS5429520B1 (hu)
AT (1) AT309696B (hu)
BE (1) BE759011A (hu)
BR (1) BR6915136D0 (hu)
CA (1) CA967564A (hu)
CH (2) CH555833A (hu)
CS (1) CS181701B2 (hu)
DE (1) DE2056327C2 (hu)
DK (1) DK128117B (hu)
ES (2) ES385590A1 (hu)
FI (1) FI54315C (hu)
FR (1) FR2073364B1 (hu)
GB (2) GB1338905A (hu)
HU (1) HU163812B (hu)
IE (1) IE34737B1 (hu)
IL (1) IL35658A (hu)
LU (1) LU62071A1 (hu)
MC (1) MC869A1 (hu)
NL (1) NL171589C (hu)
NO (1) NO128156B (hu)
PL (1) PL81167B1 (hu)
SE (1) SE385374B (hu)
YU (2) YU35033B (hu)
ZA (1) ZA707722B (hu)
ZM (1) ZM12970A1 (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
GB1562899A (en) * 1975-06-17 1980-03-19 Wellcome Found Pharmaceutical compositions containing substituted 9-( -d-arabnofuranosyl)purine-5'-phosphate and salts thereof
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
DE3319282A1 (de) * 1983-05-27 1984-11-29 Gödecke AG, 1000 Berlin Verwendung von adenosin bei der behandlung von herpes
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
CA1339964C (en) * 1988-03-16 1998-07-21 Dennis A. Carson Substituted adenine derivatives useful as therapeutic agents
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
US5292725A (en) * 1988-08-25 1994-03-08 Prendergast Patrick T Administering particular compounds against various parasites, mycoplasmas, other indications and other infections
US5681941A (en) * 1990-01-11 1997-10-28 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US5308837A (en) * 1990-08-22 1994-05-03 Merrell Dow Pharmaceuticals Inc. 5'-amine substituted adenosine analogs as immunosuppressants
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US6232463B1 (en) 1997-10-09 2001-05-15 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US6303617B1 (en) 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
ES2385931T3 (es) 2000-07-07 2012-08-03 Spectrum Pharmaceuticals, Inc. MÉTODOS PARA EL TRATAMIENTO DE NEUROPATíA PERIFÉRICA INDUCIDA POR UNA ENFERMEDAD Y AFECCIONES RELACIONADAS.
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CN105237602B (zh) * 2015-06-25 2018-05-18 新乡学院 一种2-氨基阿糖腺苷的制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070413A (en) * 1962-11-15 1967-06-01 Sankyo Co A process for preparing purine and pyrimidine nucleosides
JPH1097965A (ja) * 1996-09-20 1998-04-14 Sony Corp 生産管理方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3407191A (en) * 1966-08-29 1968-10-22 Lilly Co Eli Adamantoate esters of nucleosides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070413A (en) * 1962-11-15 1967-06-01 Sankyo Co A process for preparing purine and pyrimidine nucleosides
JPH1097965A (ja) * 1996-09-20 1998-04-14 Sony Corp 生産管理方法

Also Published As

Publication number Publication date
ZM12970A1 (en) 1972-07-21
IE34737B1 (en) 1975-08-06
YU35033B (en) 1980-06-30
DK128117B (da) 1974-03-04
NL171589B (nl) 1982-11-16
FI54315B (fi) 1978-07-31
BE759011A (fr) 1971-05-17
YU201978A (en) 1979-12-31
NL7016766A (hu) 1971-05-19
PL81167B1 (hu) 1975-08-30
NL171589C (nl) 1983-04-18
FR2073364B1 (hu) 1974-03-22
HU163812B (hu) 1973-10-27
JPS5429520B1 (hu) 1979-09-25
CH555833A (de) 1974-11-15
BR6915136D0 (pt) 1973-04-19
YU280670A (en) 1979-12-31
IL35658A0 (en) 1971-01-28
ES385590A1 (es) 1973-10-01
CS181701B2 (en) 1978-03-31
ES413787A1 (es) 1976-01-16
DE2056327A1 (de) 1971-06-03
MC869A1 (fr) 1971-09-28
FI54315C (fi) 1978-11-10
SE385374B (sv) 1976-06-28
ZA707722B (en) 1972-06-28
CA967564A (en) 1975-05-13
IE34737L (en) 1971-05-17
GB1338905A (en) 1973-11-28
IL35658A (en) 1974-10-22
CH555344A (de) 1974-10-31
NO128156B (hu) 1973-10-08
LU62071A1 (hu) 1971-08-12
US3666856A (en) 1972-05-30
DE2056327C2 (de) 1984-10-11
AT309696B (de) 1973-08-27
GB1338906A (en) 1973-11-28
YU35034B (en) 1980-06-30

Similar Documents

Publication Publication Date Title
AU2270770A (hu)
AU465452B2 (hu)
AU429630B2 (hu)
AU450150B2 (hu)
AU2355770A (hu)
AU442375B2 (hu)
AU427401B2 (hu)
AU470301B1 (hu)
AU442380B2 (hu)
AU442554B2 (hu)
AU428074B2 (hu)
AU428129B2 (hu)
AU428131B2 (hu)
AU417208B2 (hu)
AU470661B1 (hu)
AU438128B2 (hu)
AU425297B2 (hu)
AU442285B2 (hu)
AU442322B2 (hu)
AU442357B2 (hu)
AU414607B2 (hu)
AU410358B2 (hu)
AU442463B2 (hu)
AU442535B2 (hu)
AU4815038A (hu)

Legal Events

Date Code Title Description
ST Notification of lapse